Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
A new study revealed, Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, has helped obese people lose an average of 18 pounds (eight kilograms). The findings are published in the New England Journal of Medicine.
Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, launch generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States which are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.
A single-celled marine plankton evolved a miniature version of a multi-cellular eye, possibly to help see its prey better, according to University of British Columbia (UBC) research published today in Nature.
[adsense:336x280:8701650588]
Pinaverium bromide (pinaverium), an antispasmodic, is used widely in many countries around the world, including European countries, Canada and Mexico. However, original clinical studies on pinaverium are scarce and there has been no convincing evidence for its effectiveness and safety. As such, the U.S. Food and Drug Administration (FDA) has not approved this treatment for use in the U.S. IBS is the most common chronic (life-long in some patients) and highly recurrent gastrointestinal disorder, with an estimated worldwide prevalence of 10 to 15%.
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans. The study was published in the journal PLOS ONE
Males may play a positive role in the development of offspring's brain even before pregnancy starts, says a study. The research found that female mice exposed to male pheromones gave birth to infants with greater mental ability. The study was published in the journal Proceedings of the Royal Society of London B: Biological Sciences.
A method developed by a team of Israeli scientists to decode an individual's unique sense of smell which they call an "olfactory fingerprint" has been found, claims a new research. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS). This "olfactory fingerprinting", in addition to help identify individuals, can detect diseases such as Parkinson's and Alzheimer's early.
A diet high in fat and sugar causes changes in gut bacteria, lead to significant loss of cognitive function compared to normal diet. The research is published in Journal Neuroscience.
Glenmark Pharmaceuticals, has received approval from the US Food and Drug Administration (US FDA) for its cholesterol-lowering drug Ezetimibe. Ezetimibe is the generic version of Merck-Schering Plough's cholesterol-lowering drug with the product name Zetia.
Multiplicom N.V., announced the launch of a new gene panel, the CLL MASTR Plus kit, to improve the diagnosis of patients with chronic lymphocytic leukaemia.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
